FILTER

Refine your search with the following facets to narrow down your results.

4 Current news of PATH

Mucosis B.V. and PATH Sign Agreement to Pursue Mimopath-Based Oral Diarrhea Vaccines

01-Oct-2010 - Mucosis B.V. announced that it has entered into a collaboration agreement with the global health nonprofit organization PATH to pursue the use of the company’s Mimopath™ technology in oral vaccines to prevent and treat severe diarrhea. Severe dehydrating diarrhea is the second leading cause of ...

diarrhea vaccines

World's largest malaria vaccine trial now underway in 7 African countries

05-Nov-2009 - A pivotal efficacy trial of RTS,S, a clinically advanced malaria vaccine candidate, is now underway in seven African countries: Burkina Faso, Gabon, Ghana, Kenya, Malawi, Mozambique and Tanzania. The trial, which is expected to involve up to 16,000 children, is on schedule, with more than 5,000 ...

clinical trials diseases GSK +5

PATH Malaria Vaccine Initiative and Crucell to test new malaria vaccine approach

30-Jul-2009 - The US-based PATH Malaria Vaccine Initiative (MVI), the United States Agency for International Development (USAID) Malaria Vaccine Development Program (MVDP), and Crucell N.V. announced a collaboration to accelerate development of a promising type of malaria vaccine. Through funding from the ...

adenovirus Crucell immunogenicity +1

Collaboration of Intercell with PATH for the development of Intercell's Streptococcus pneumoniae vaccine

08-Sep-2006 - Intercell and PATH, a USbased nonprofit organization dedicated to finding solutions for global health issues announced an agreement to advance the development of Intercell's Streptococcus pneumoniae vaccine. Intercell will receive a total of USD 7.3 m during the first stage of the collaboration, ...

clinical trials Intercell pneumonia +2